Abstract:AIM: Angiogenesis is an important step in the growth of solid malignant tumors. A number of angiogenic factors have been found such as transforming growth factorbeta1 (TGF-beta1) and vascular endothelial growth factor (VEGF). However, the roles of TGFbeta1 and VEGF in gastrointestinal carcinogenesis are still unclear. This study was to investigate the expressions of TGF-beta1 and VEGF in gastrointestinal tract malignant tumors, as well as their association with microvessel density (MVD). At the same time, we also observed the localization of TGF-beta1 and its receptor CD105 in gastric malignant tumors.METHODS: The expressions of TGF-beta1 and CD105 were detected in 55 fresh specimens of gastric carcinoma and VEGF and CD105 in 44 fresh specimens of colorectal carcinoma by immunohistochemical staining (S-ABC). TGF-beta1 and CD105 in 55 gastric carcinoma tissues on the same slide were detected by using double-stain Immunohistochemistry (DS-ABC).RESULTS: Among the 55 cases of gastric carcinoma tissues, 30 were positive for TGF-beta1 (54.55 %). The MVD of TGF-beta1 strong positive group (++similar to+++ 23.22+/-5.8) was significantly higher than that of weak positive group (+17.56+/-7.2) and negative group (- 17.46+/-3.9) (q=4.5, q=5.3207, respectively, P<0.01). In the areas of high expression of TGF-beta1, MVD and the expression of CD105 were also high. Among the 44 cases of colonic carcinoma tissues, 26 were positive for VEGF (59.1 %). The expressions of both VEGF and CD105 (MVD) were related with the depth of invasion (F=5.438, P<0.05; F=4.168, P=0.05), lymph node metastasis (F=10.311, P<0.01; F=20.282, P<0.01) and Dukes stage (F=6.196, P<0.01; F=10.274, P<0.01), but not with histological grade (F=0.487, P>0.05). There was a significant correlation between the expression of VEGF and CD105 (MVD) (r=0.720, P<0.01).CONCLUSION: Over-expression of TGF-beta1 and VEGF acts as stimulating factors of angiogenesis in gastrointestinal tumors. CD105, as a receptor of TGF-beta1, can regulate the biological effect of TGF-beta1 in tumor angiogenesis. MVD marked by CD105 is more suitable for detecting newborn blood vessels.

Expression and Significance of CD105 in Giant Cell Tumor of Bone

Expression and Significance of CD105 ,MMP-2 and MMP-9 in Giant Cell Tumor of Bone

Expression and Clinical Significance of Protein CD133 in Giant Cell Tumor of Bone

Expressions of CD133 and Ki-67 in giant cell tumor of bone and their clinical significance

Study on the Expression and Clinical Significance of CD105 in Pancreatic Carcinoma

Expression of Matrix Metalloproteinase‐9 and CD34 in Giant Cell Tumor of Bone

Expression of CD147, PCNA, VEGF, MMPs and Their Clinical Significance in the Giant Cell Tumor of Bones.

Expressions of P53, Vascular Endothelial Growth Factor in Giant Cell Tumors of Bone and Their Significance

Immunohistochemical Study of Association of Angiogenesis and Expression of TGFβ_1 and TGFβ_3 with Prognosis in Giant Cell Tumor of Bone

Relationship Between Expression Of Cd105 And Growth Factors In Malignant Tumors Of Gastrointestinal Tract And Its Significance

Significance of CD105 expression in laryngeal carcinoma

Expression of Vascular Endothelial Growth Factor and KDR in Giant Cell Tumor of Bone and Their Relationship with Tumor Proliferation and Angiogenesis

Relation Between M-CSF Expression and Patho-classification or Biological Behaviors of Giant Cell Tumor of Bone

The Expressions of Matrix Metalloproteinase-2 in Giant Cell Tumors of Bone and Its Significance

The expression of VEGF and Survivin in giant cell tumor of bone and the correlation with prognosis

Expression and Significance of Ets-1, C-Myc in Giant Cell Tumor of Bone

SigniifcanceofquantitativeanalysisofenhancedCTscaninthequalitativediagnosisofthegiantcelltumorof ;the bone

The Expressions of P53 and C-Myc in Giant Cell Tumors of Bone

Hypoxia-inducible factor expression in giant cell tumor of bone and its relationship with different pathological types

Tumor immunohistochemistry and preoperative magnetic resonance imaging features predict local recurrence of giant cell tumor of bone following intralesional curettage.

Factors related to biologic behavior in giant cell tumor of bone